5,520 research outputs found
Geometry and seismic properties of the subducting Cocos plate in central Mexico
The geometry and properties of the interface of the Cocos plate beneath central Mexico are determined from the receiver functions (RFs) utilizing data from the Meso America Subduction Experiment (MASE). The RF image shows that the subducting oceanic crust is shallowly dipping to the north at 15° for 80 km from Acapulco and then horizontally underplates the continental crust for approximately 200 km to the Trans-Mexican Volcanic Belt (TMVB). The crustal image also shows that there is no continental root associated with the TMVB. The migrated image of the RFs shows that the slab is steeply dipping into the mantle at about 75° beneath the TMVB. Both the continental and oceanic Moho are clearly seen in both images, and modeling of the RF conversion amplitudes and timings of the underplated features reveals a thin low-velocity zone between the plate and the continental crust that appears to absorb nearly all of the strain between the upper plate and the slab. By inverting RF amplitudes of the converted phases and their time separations, we produce detailed maps of the seismic properties of the upper and lower oceanic crust of the subducting Cocos plate and its thickness. High Poisson's and Vp/Vs ratios due to anomalously low S wave velocity at the upper oceanic crust in the flat slab region may indicate the presence of water and hydrous minerals or high pore pressure. The evidence of high water content within the oceanic crust explains the flat subduction geometry without strong coupling of two plates. This may also explain the nonvolcanic tremor activity and slow slip events occurring in the subducting plate and the overlying crust
Vector field mediated models of dynamical light velocity
A vector-tensor theory of gravity that was introduced in an earlier
publication is analyzed in detail and its consequences for early universe
cosmology are examined. The multiple light cone structure of the theory
generates different speeds of gravitational and matter wave fronts, and the
contraction of these light cones produces acausal, superluminary inflation that
can resolve the initial value problems of cosmology.Comment: 16 pages, uses amsar
Functional genomic analysis and neuroanatomical localization of miR-2954, a song-responsive sex-linked microRNA in the zebra finch
Natural experience can cause complex changes in gene expression in brain centers for cognition and perception, but the mechanisms that link perceptual experience and neurogenomic regulation are not understood. MicroRNAs (miRNAs or miRs) have the potential to regulate large gene expression networks, and a previous study showed that a natural perceptual stimulus (hearing the sound of birdsong in zebra finches) triggers rapid changes in expression of several miRs in the auditory forebrain. Here we evaluate the functional potential of one of these, miR-2954, which has been found so far only in birds and is encoded on the Z sex chromosome. Using fluorescence in situ hybridization and immunohistochemistry, we show that miR-2954 is present in subsets of cells in the sexually dimorphic brain regions involved in song production and perception, with notable enrichment in cell nuclei. We then probe its regulatory function by inhibiting its expression in a zebra finch cell line (G266) and measuring effects on endogenous gene expression using Illumina RNA sequencing (RNA-seq). Approximately 1000 different mRNAs change in expression by 1.5-fold or more (adjusted p < 0.01), with increases in some but not all of the targets that had been predicted by Targetscan. The population of RNAs that increase after miR-2954 inhibition is notably enriched for ones involved in the MAP Kinase (MAPK) pathway, whereas the decreasing population is dominated by genes involved in ribosomes and mitochondrial function. Since song stimulation itself triggers a decrease in miR-2954 expression followed by a delayed decrease in genes encoding ribosomal and mitochondrial functions, we suggest that miR-2954 may mediate some of the neurogenomic effects of song habituation
Helicobacter pylori infection is associated with an increased rate of diabetes.
ObjectiveChronic infections could be contributing to the socioeconomic gradient in chronic diseases. Although chronic infections have been associated with increased levels of inflammatory cytokines and cardiovascular disease, there is limited evidence on how infections affect risk of diabetes.Research design and methodsWe examined the association between serological evidence of chronic viral and bacterial infections and incident diabetes in a prospective cohort of Latino elderly. We analyzed data on 782 individuals aged >60 years and diabetes-free in 1998-1999, whose blood was tested for antibodies to herpes simplex virus 1, varicella virus, cytomegalovirus, Helicobacter pylori, and Toxoplasma gondii and who were followed until June 2008. We used Cox proportional hazards regression to estimate the relative incidence rate of diabetes by serostatus, with adjustment for age, sex, education, cardiovascular disease, smoking, and cholesterol levels.ResultsIndividuals seropositive for herpes simplex virus 1, varicella virus, cytomegalovirus, and T. gondii did not show an increased rate of diabetes, whereas those who were seropositive for H. pylori at enrollment were 2.7 times more likely at any given time to develop diabetes than seronegative individuals (hazard ratio 2.69 [95% CI 1.10-6.60]). Controlling for insulin resistance, C-reactive protein and interleukin-6 did not attenuate the effect of H. pylori infection.ConclusionsWe demonstrated for the first time that H. pylori infection leads to an increased rate of incident diabetes in a prospective cohort study. Our findings implicate a potential role for antibiotic and gastrointestinal treatment in preventing diabetes
Online Advice Taking: Examining the Effects of Self-Efficacy, Computerized Sources, and Perceived Credibility
The Internet offers limitless advice on a multitude of products and services. The quality of the advice varies and is inherently a matter of human judgment. To help users determine the quality of advice and whether to use the advice, design features of web sites include information about the type and credibility of the advice source. This research examines how characteristics of the online user (i.e., self-efficacy) and characteristics of the advice source (i.e., type and credibility) affect advice taking in an online investing context. A laboratory experiment provides evidence that users with higher levels of self-efficacy are less likely to take advice than those with lower levels of self-efficacy. Results also suggest users given highly credible advice are more likely to take the advice compared to users who receive advice with dubious credibility. The implications are discussed
Regulation of Serum Response Factor and Adiponectin by PPARγ Agonist Docosahexaenoic Acid
Recent studies indicate that significant health benefits involving the regulation of signaling proteins result from the consumption of omega-3 polyunsaturated fatty acids (ω-3 PUFAs). Serum response factor (SRF) is involved in transcriptional regulation of muscle growth and differentiation. SRF levels are increased in the aging heart muscle. It has not been examined whether SRF is made by adipocytes and whether SRF secretion by adipocytes is modulated by PPARγ agonist DHA.
Adiponectin is made exclusively by adipocytes. We and others have previously reported that PUFAs such as DHA increase adiponectin levels and secretion in adipocytes. Here we show that DHA downregulates SRF with a simultaneous upregulation of adiponectin and that both these responses are reversible by PPARγ antagonist. Furthermore, there appears to be a direct relationship between DHA exposure and increased levels of membrane-associated high-density adiponectin, as well as lower levels of membrane-associated SRF. Thus, we find that the levels of SRF and adiponectin are inversely related in response to treatment with PPARγ agonist DHA. Decreased levels of SRF along with increase in membrane-associated adiponectin could in part mediate the health benefits of DHA
Are Ti44-Producing Supernovae Exceptional?
According to standard models supernovae produce radioactive Ti, which
should be visible in gamma-rays following decay to Ca for a few
centuries. ^{44}^{44}\tau \simeq\simeq\simeq^{44}Ti gamma-ray sources, but only
one is clearly seen, the 340-year-old Cas A SNR. Furthermore, supernovae which
produce much ^{44}Ti yields, their spatial
distributions, and statistical arguments can be stretched so that this apparent
disagreement may be accommodated within reasonable expectations, or if we have
to revise some or all of the above aspects to bring expectations in agreement
with the observations. We conclude that either core collapse supernovae have
been improbably rare in the Galaxy during the past few centuries, or
^{44}^{40}^{44}$Ca.Comment: 23 pages, 14 figures, accepted for publication in Astronomy and
Astrophysics 2006. Correcting the SN type of Tycho in Table B.1. and add its
associated reference
Insurance Coverage Policies for Pharmacogenomic and Multi-Gene Testing for Cancer
Abstract: Insurance coverage policies are a major determinant of patient access to genomic tests. The objective of this study was to examine differences in coverage policies for guideline-recommended pharmacogenomic tests that inform cancer treatment. We analyzed coverage policies from eight Medicare contractors and 10 private payers for 23 biomarkers (e.g., HER2 and EGFR) and multi-gene tests. We extracted policy coverage and criteria, prior authorization requirements, and an evidence basis for coverage. We reviewed professional society guidelines and their recommendations for use of pharmacogenomic tests. Coverage for KRAS, EGFR, and BRAF tests were common across Medicare contractors and private payers, but few policies covered PML/RARA, CD25, or G6PD. Twelve payers cover at least one multi-gene test for nonsmall cell lung cancer, citing emerging clinical recommendations. Coverage policies for single and multi-gene tests for cancer treatments are relatively consistent among Medicare contractors despite the lack of national coverage determinations. In contrast, coverage for these tests varied across private payers. Patient access to tests is governed by prior authorization among eight private payers. Substantial variations in how payers address guideline-recommended pharmacogenomic tests and the common use of prior authorization underscore the need for additional studies of the effects of coverage variation on cancer care and patient outcomes
- …